Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.72
+0.07000.25%
Pre-market: 27.960.2400+0.87%07:42 EDT
Volume:25.56M
Turnover:705.42M
Market Cap:157.61B
PE:36.48
High:27.85
Open:27.80
Low:27.42
Close:27.65
52wk High:29.21
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.91
T/O Rate:0.45%
Dividend:1.72
Dividend Rate:6.20%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.85
PE(LYR):20.32

Loading ...

FDA Approves Pfizer Padcev-keytruda Combo for Perioperative Muscle-invasive Bladder Cancer

Reuters
·
Jul 10

U.S. FDA Approves Padcev® Plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-invasive Bladder Cancer Regardless of Cisplatin Eligibility

THOMSON REUTERS
·
Jul 10

FDA: Approves Pembrolizumab or Pembrolizumab and Berahyaluronidase Alfa-pmph Each with Enfortumab Vedotin-ejfv for Muscle Invasive Bladder Cancer

THOMSON REUTERS
·
Jul 10

BofA Securities Adjusts Pfizer Price Target to $26 From $27

MT Newswires Live
·
Jul 10

Pfizer Seen Reporting Q2 Revenue In Line With Consensus, EPS Below Estimates, RBC Says

MT Newswires Live
·
Jul 10

Market Chatter: Pfizer's Vaccine Disputes With Poland, Romania Continue

MT Newswires Live
·
Jul 10

Pfizer price target lowered to $26 from $27 at BofA

TIPRANKS
·
Jul 10

German Lawmakers Approve Healthcare Shake-up Aimed at Taming Costs

Reuters
·
Jul 10

Pfizer Stock Leads 3 AI Healthcare Picks Worth A Closer Look

Simply Wall St.
·
Jul 10

NYSE Most Active Issues

Dow Jones
·
Jul 10

US Appeals Court Upholds Win for Astrazeneca in Pfizer Cancer Drug Patent Fight

Reuters
·
Jul 10

Appeals court upholds win for AstraZeneca in Pfizer patent fight, Reuters says

TIPRANKS
·
Jul 10

Pfizer Advances RSV Vaccine Strategy With New Phase 3 Trial in India

TIPRANKS
·
Jul 10

Pfizer Refines Early-Stage Drug Formulations With New Phase 1 Bioavailability Study

TIPRANKS
·
Jul 10

Ping An Good Doctor and Pfizer China Forge Partnership to Advance Integrated Healthcare, Pharmaceutical, Insurance, and Patient Pathways

Deep News
·
Jul 09

Astrazeneca's Wainua Fails Key Heart Disease Trial, Shares Tumble

Reuters
·
Jul 09

NYC High-rise Scare is Harsh Reality Check for Office-to-apartment Conversion Boom

Dow Jones
·
Jul 09

What We Know About Efforts to Stabilize the Former Pfizer Building in Manhattan

Dow Jones
·
Jul 09

Pfizer is Maintained at Neutral by JP Morgan

Dow Jones
·
Jul 08

JPMorgan Adjusts Price Target on Pfizer to $28 From $30

MT Newswires Live
·
Jul 08